Abstract
Interleukin (IL)-1 is a multifunctional cytokine that plays a key role in mediating inflammation in the brain. Many different cell types in the brain express the IL-1 receptor and respond to this cytokine by activating cell-type-specific signaling pathways leading to distinct functional responses, which collectively comprise the inflammatory response in the brain. One key effect of IL-1 in the brain is the induction of trophic factor production by glial cells, which has traditionally been considered a neuroprotective response to injury or disease. However, recent studies have shown that nerve growth factor, which is regulated by IL-1, can induce neuronal survival or apoptosis via different receptors. This article examines the interaction of IL-1 with different trophic factors in the brain.
Similar content being viewed by others
References
Sims J. E., Gayle M. A., Slack J. L., et al. (1993) Interleukin 1 signaling occurs exclusively via the type 1 receptor. Proc. Natl. Acad. Sci. USA 90, 6155–6159.
O’Neill L. A. and Dinarello C. A. (2000) The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today 21, 206–209.
Hannum C. H., Wilcox C. J., Arend W. P., et al. (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343, 336–340.
Colotta F., Re F., Muzio M., et al. (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261, 472–475.
Rothwell N. J. and Luheshi G. N. (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23, 618–625.
Dascombe M. J. (1985) The pharmacology of fever. Progress Neurobiol. 25, 327–373.
Fang J. D., Wang Y., and Krueger J. M. (1998) Effects of interleukin-1β[???] on sleep are mediated by the type 1 receptor. Am. J. Physiol. 43, R655-R660.
Berkenbosch F., Van Oers J., Del Rey A., Tilders F., and Besedovsky H. (1987) Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238, 524–526.
Sapolsky R., Rivier C., Yamamoto G., Plotsky P., and Vale W. (1987) Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238, 522–524.
Basu A., Krady J. K., and Levison S. W. (2004) Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 78, 151–156.
John G. R., Lee S. C., Song X., Rivieccio M., and Brosnan C. F. (2005) IL-1-regulated resonses in astrocytes: relevance to injury and recovery. Glia 49, 161–176.
Vela J. M., Molina-Holgado E., Arevalo-Martin A., Almazan G., and Guaza C. (2002) Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol. Cell Neurosci. 20, 489–502.
Bellinger F. P., Madamba S., and Siggins G. R. (1993) Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628, 227–234.
Murray C. A. and Lynch M. A. (1998) Evidence that increased hippocampal expression of the cytokine interleukin-1B is a common trigger for age- and stress-induced impairments in long-term potentiation. J. Neurosci. 18, 2974–2981.
O’Connor J. J. and Coogan A. N. (1999) Actions of the pro-inflammatory cytokine IL-1 beta on central synaptic transmission. Exp. Physiol. 84, 601–614.
Vitkovic L., Bockaert J., and Jacque C. (2000) “Inflammatory” cytokines: neuromodulators in normal brain? J. Neurochem. 74, 457–471.
Nieto-Sampedro M. and Berman M. A. (1987) Interleukin-1-like activity in rat brain: sources, targets, and effect of injury. J. Neurosci. Res. 17, 214–219.
Giulian D. (1987) Ameloid microglia as effectors of inflammation in the central nervous system. J. Neurosci. Res. 18, 155–171.
Davies C. A., Loddick S. A., Toulmond S., Stroemer R. P., Hunt J., and Rothwell N. J. (1999) The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 19, 87–98.
Pearson V. L., Rothwell N. J., and Toulmond S. (1999) Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia 25, 311–323.
Benveniste E. N. (1992) Cytokines: influence on glial cell gene expression and function. In: Neuroimmunoendocrinology, 52, Blalock J. E., ed. Karger, Basel, pp. 106–153.
Merrill J. E. and Benveniste E. N. (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19, 331–338.
Basu A., Krady J. K., O’Malley M., Styren S. D., DeKosky S. T. and Levison S. W. (2002) The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J. Neurosci. 22, 6071–6082.
Lee S. C., Liu W., Dickson D. W., Brosnan C. F. and Berman J. W. (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150, 2659–2667.
Sparacio S. M., Zhang Y., Vilcek J., and Benveniste E. N. (1992) Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κB-like nuclear protein. J. Neuroimmunol. 39, 231–242.
Chung I. Y. and Benveniste E. N. (1990) Tumor necrosis factor-a production by astrocytes: induction by lipopolysaccharide, IFN-g, and IL-1B. J. Immunol. 144, 2999–3007.
Aloisi F., Care A., Borsellino G., et al. (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 149, 2358–2366.
Cunningham E. T. Jr., Wada E., Carter D. B., Tracey D. E., Battey J. F., and De Souza E. B. (1992) In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system pituitary, and adrenal gland of the mouse. J. Neurosci. 12, 1101–1114.
Yabuuchi K., Minami M., Katsumata S., and Satoh M. (1994) Localization of type 1 interleukin-1 receptor mRNA in rat brain. Mol. Brain Res. 27, 27–36.
Ericsson A., Liu C., Hart R. P. and Sawchenko P. E. (1995) Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1 cellular activation. J. Comp. Neurol. 361, 681–698.
Friedman W. J. (2001) Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Exp. Neurol. 168, 23–31.
Katsuki H., Nakai S., Hirai Y., Akaji K., Kiso Y., and Satoh M. (1990) Interleukin-1B inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 181, 323–326.
Kelly A., Lynch A., Vereker E., et al. (2001) The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1 beta on long term potentiation. A role for JNK. J. Biol. Chem. 276, 45,564–45,572.
Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., and Besedovsky H. O. (1998) A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl. Acad. Sci. USA 95, 7778–7783.
Ross F. M., Allan S. M., Rothwell N. J., and Verkhratsky A. (2003) A dual role for interleukin-1 in LTP in mouse hippocampal slices. J. Neuroimmunol. 144, 61–67.
Li Y., Liu L., Barger S. W., and Griffin W. S. T. (2003) Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J. Neurosci. 23, 1605–1611.
O’Neill L. A. and Greene C. (1998) Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukoc. Biol. 63, 650–657.
Friedman W. J., Thakur S., Seidman L., and Rabson A. B. (1996) Regulation of nerve growth factor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NFκB. J. Biol. Chem. 271, 31,115–31,120.
Heese K., Hock C., and Otten U. (1998) Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70, 699–707.
Dunne A. and O’Neill L. (2003) The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Science STKE 171, re3.
O’Neill L. (2002) Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr. Top. Microbiol. Immunol. 270, 47–61.
Coogan A. N., O’Neill L. A. J., and O’Connor J. J. (1999) The p38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1 on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93, 57–69.
Srinivasan D., Yen J. -H., Joseph D. J., and Friedman W. J. (2004) Cell type specific interleukin-1β signaling in the central nervous system. J. Neurosci. 24, 6482–6488.
Barde Y. A. (1990) The nerve growth factor family. Prog. Growth Factor Res. 2, 237–248.
Huang E. J. and Reichardt L. F. (2001) Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677–736.
Baloh R. H., Enomoto H., Johnson E. M. Jr., and Milbrandt J. (2000) The GDNF family ligands and receptors—implications for neural development. Curr. Opin. Neurobiol. 10, 103–110.
Patterson P. H. (1992) The emerging neuropoietic cytokine family: first CDF/LIF, CNTF, and IL-6; next ONC, MGF, GCSF? Curr. Opin. Neurobiol. 2, 94–97.
Murphy M., Dutton R., Koblar S., Cheema S., and Bartlett P. (1997) Cytokines which signal through the LIF receptor and their actions in the nervous system. Prog. Neurobiol. 52, 355–378.
Muller-Newen G. (2003) The cytokine receptor gp130: faithfully promiscuous. Science STKE 2003, PE40.
Ip N. Y., Wiegand S. J., Morse J., and Rudge J. S. (1993) Injury-induced regulation of ciliary neurotrophic factor mRNA in the adult brain. Eur. J. Neurosci. 5, 25–33.
Herx L. M., Rivest S., and Yong V. W. (2000) Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J. Immunol. 165, 2232–2239.
Winter C. G., Saotome Y., Levison S. W., and Hirsch D. (1995) A role for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central nervous system injury. Proc. Natl. Acad. Sci. USA 92, 5865–5869.
Levison S. W., Ducceschi M. H., Young G. M., and Wood T. L. (1996) Acute exposure to CNTF in vivo induces multiple components of reactive gliosis. Exp. Neurol. 141, 256–268.
Sendtner M., Kreutzberg G. W., and Thoenen H. (1990) Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345, 440,441.
Oppenheim R. W., Prevette D., Yin Q. W., Collins F., and MacDonald J. (1991) Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science 251, 1616–1618.
Masu Y., Wolf E., Holtmann B., Sendtner M., Brem G., and Thoenen H. (1993) Disruption of the CNTF gene results in motor neuron degeneration. Nature 365, 27–32.
Richardson P. M. (1994) Ciliary neurotrophic factor: a review. Pharmacol. Ther. 63, 187–198.
Alberch J., Perez-Navarro E., and Canals J. M. (2004) Neurotrophic factors in Huntington’s disease. Prog. Brain Res. 146, 195–229.
Louis J. C., Magal E., Takayama S., and Varon S. (1993) CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259, 689–692.
Linker R. A., Maurer M., Gaupp S., et al. (2002) CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat. Med. 8, 620–624.
Frautschy S. A., Walicke P. A., and Baird A. (1991) Localization of basic fibroblast growth factor and its mRNA after CNS injury. Brain Res. 553, 291–299.
Gomez-Pinilla F., Lee J. W., and Cotman C. W. (1992) Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria-fornix transection. J. Neurosci. 12, 345–355.
Alzheimer C. and Werner S. (2002) Fibroblast growth factors and neuroprotection. Adv. Exp. Med. Biol. 513, 335–351.
Yoshimura S., Takagi Y., Harada J., et al. (2001) FGF-2 regulation of neurogenesis in adult hippocampus after brain injury. Proc. Natl. Acad. Sci. USA 98, 5874–5879.
Jiang F., Levison S. W., and Wood T. L. (1999) Ciliary neurotrophic factor induces expression of the IGF type I receptor and FGF receptor 1 mRNAs in adult rat brain oligodendrocytes. J. Neurosci. Res. 57, 447–457.
Albrecht P. J., Dahl J. P., Stoltzfus O. K., Levenson R., and Levison S. W. (2002) Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp. Neurol. 173, 46–62.
Gomez-Pinilla F., Vu L., and Cotman C. W. (1995) Regulation of astrocyte proliferation by FGF-2 and heparan sulfate in vivo. J. Neurosci. 15, 2021–2029.
Belluardo N., Wu G., Mudo G., Hansson A. C., Pettersson R., and Fuxe K. (1997) Comparative localization of fibroblast growth factor receptor-1,-2, and -3 mRNAs in the rat brain: in situ hybridization analysis. J. Comp. Neurol. 379, 226–246.
Jing S., Wen D., Yu Y., et al. (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-a, a novel receptor for GDNF. Cell 85, 1113–1124.
Trupp M., Arenas E., Fainzilber M., et al. (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381, 785–789.
Durbec P., Marcos-Gutierrez C. V., Kilkenny C., et al. (1996) GDNF signalling through the ret receptor tyrosine kinase. Nature 381, 789–793.
Oppenheim R. W., Houenou L. J., Johnson J. E., et al. (1995) Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373, 344–346.
Lin L. -F. H., Doherty D. H., Lile J. D., Bektesh S., and Collins F. (1993) GDNF: a gial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130–1132.
Beck K. D., Valverde J., Alexi T., et al. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339–341.
Arenas E., Trupp M., Åkerud P., and Ibáñez C. F. (1995) GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15, 1465–1473.
Perez-Navarro E., Arenas E., Reiriz J., Calvo N., and Alberch J. (1996) Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage. Neuroscience 75, 345–352.
Henderson C. E., Phillips H. S., Pollock R. A., et al. (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and nuscle. Science 266, 1062–1064.
Yan Q., Matheson C., and Lopez O. T. (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373, 341–344.
Tomac A., Lindqvist E., Lin L. -F. H., et al. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335–339.
Humpel C., Hoffer B., Strömberg I., Bektesh S., Collins F., and Olson L. (1994) Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience 59, 791–795.
Barbacid M. (1994) The trk family of neurotrophin receptors. J. Neurobiol. 25, 1386–1403.
Friedman W. J. and Greene L. A. (1999) Neurotrophin signaling via Trks and p75. Exp. Cell Res. 253, 131–142.
Patapoutian A. and Reichardt L. F. (2001) Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 11, 272–280.
Levi-Montalcini R. and Angeletti P. U. (1968) The nerve growth factor. Physiol. Rev. 48, 534–569.
Levi-Montalcini R. (1987) The nerve growth factor 35 years later. Science 237, 1154–1162.
Thoenen H. and Barde Y. A. (1980) Physiology of nerve growth factor. Physiol. Rev. 60, 1284–1335.
Barde Y. A. (1994) Neurotrophins: a family of proteins supporting the survival of neurons. Prog. Clin. Biol. Res. 390, 45–56.
Kaplan D. R., Hempstead B., Martin-Zanca D., Chao M. V., and Parada L. F. (1991) The trk proto-oncogene product is a receptor for nerve growth factor. Science 252, 554–558.
Klein R., Jing S., Nanduri V., O’Rourke E., and Barbacid M. (1991) The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65, 189–197.
Hofer M. M. and Barde Y. -A. (1988) Brain-derived neurotrophic factor prevents neuronal death in vivo. Nature 331, 261,262.
Oppenheim R. W., Yin Q. W., Prevette D., and Yan Q. (1992) Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 360, 755–757.
Klein R., Smeyne R. J., Wurst W., et al. (1993) Targeted disruption of the trkB neurotrophin receptor gene rsults in nervous system lesions and neonatal death. Cell 75, 113–122.
Minichiello L. and Klein R. (1996) TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons. Genes Dev. 10, 2849–2858.
Sendtner M., Holtman B., Kolbeck R., Thoenen H., and Barde Y. -A. (1992) Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 360, 757–759.
Spina M. B., Squinto S. P., Miller J., Lindsay R. M., and Hyman C. (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59, 99–106.
Yan Q., Elliott J., and Snider W. D. (1992) Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 360, 753–755.
Giehl K. M. and Tetzlaff W. (1996) BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo. Eur. J. Neurosci. 8, 1167–1175.
Alcantara S., Frisen J., del Rio J. A., Soriano E., Barbacid M., and Silos-Santiago I. (1997) TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J. Neurosci. 17, 3623–3633.
Patterson S. L., Abel T., Deuel T. A. S., Martin K. C., Rose J. C., and Kandel E. R. (1996) Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16, 1137–1145.
Korte M., Griesbeck O., Gravel C., et al. (1996) Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proc. Natl. Acad. Sci. USA 93, 12,547–12,552.
Martinez A., Alcantara S., Borrell V., et al. (1998) TrkB and TrkC signaling are required for maturation and synaptogenesis of hippocampal connections. J. Neurosci. 18, 7336–7350.
Holtzman D. M., Li Y., Parada L. F., et al. (1992) p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron 9, 465–478.
Fagan A. M., Garber M., Barbacid M., Silos-Santiago I., and Holtzman D. M. (1997) A role for trkA during maturation of striatal and basal forebrain cholinergic neurons in vivo. J. Neurosci. 17, 7644–7654.
Ringstedt T., Lagercrantz H., and Persson H. (1993) Expression of members of the trk family in the developing postnatal rat brain. Dev. Brain Res. 72, 119–131.
Williams L. R., Varon S., Peterson G. M., Wictorin K., Björklund A., and Gage F.H. (1986) Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. USA 83, 9231–9235.
Fischer W., Wictorin K., Björklund A., Williams L. R., Varon S., and Gage F. H. (1987) Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329, 65–68.
Kromer L. F. (1987) Nerve growth factor treatment after brain injury prevents neuronal death. Science 235, 214–216.
Ayer LeLievre C., Olson L., Ebendal T., Seiger A., and Persson H. (1988) Expression of the beta-nerve growth factor gene in hippocampal neurons. Science 240, 1339–1341.
Phillips H. D., Hains J. M., Laramee G. R., Rosenthal A., and Winslow J. W. (1990) Widespread expression of BDNF but not NT-3 by target areas of basal forebrain cholinergic neurons. Science 250, 290–294.
Maisonpierre P. C., Belluscio L., Friedman B., et al. (1990) NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression. Neuron 5, 501–509.
Ernfors P., Merlio J.-P., and Persson H. (1992) Cells expressing mRNA for neurotrophins and their receptors during embryonic rat development. Eur. J. Neurosci. 4, 1140–1158.
Spranger M., Lindholm D., Bandtlow C., et al. (1990) Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2, 69–76.
Gadient R. A., Cron K. C., and Otten U. (1990) Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci. Lett. 117, 335–340.
Carman-Krzan M., Vigé X., and Wise B. C. (1991) Regulation by interleukin-1 of nerve growth factor secretion and nerve growth factor mRNA expression in rat primary astroglial cultures. J. Neurochem. 56, 636–643.
Oderfeld-Nowak B. and Bacia A. (1994) Expression of astroglial nerve growth factor in damaged brain. Acta. Neurobiol. Exp. 54, 73–80.
Goss J. R., O’Malley M. E., Zou L., Styren S. D., Kochanek P. M., and DeKoskey S. T. (1998) Astrocytes are the major source of nerve growth factor upregulation following traumatic brain injury in the rat. Exp. Neurol. 149, 301–309.
Micera A., Vigneti E., and Aloe L. (1998) Changes of NGF presence in nonneuronal cells in response to experimental allergic encephalomyelitis in Lewis rats. Exp. Neurol. 154, 41–46.
Gage F. H., Batchelor P., Chen K. S., et al. (1989) NGF receptor reexpression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum. Neuron 2, 1177–1184.
Ernfors P., Henschen A., Olson L., and Persson H. (1989) Expression of nerve growth factor receptor mRNA is developmentally regulated and increased after axotomy in rat spinal cord motoneurons. Neuron 2, 1605–1613.
Peterson S. and Bogenmann E. (2003) Osmotic swelling induces p75 neurotrophin receptor (p75NTR) expression via nitric oxide. J. Biol. Chem. 278, 33,943–33,950.
Casaccia-Bonnefil P., Kong H., and Chao M. V. (1998) Neurotrophins: the biological paradox of survival factors eliciting apoptosis [see comments]. Cell Death Differ. 5, 357–364.
Barker P. A. (1998) p75NTR: a study in contrasts [see comments]. Cell Death Differ. 5, 346–356.
Miller F. D. and Kaplan D. R. (1998) Life and death decisions: a biological role for the p75 neurotrophin receptor [editorial; comment]. Cell Death Differ. 5, 343–345.
Rabizadeh S., Oh J., Zhong L., et al. (1993) Induction of apoptosis by the low-affinity NGF receptor. Science 261, 345–358.
Casaccia-Bonnefil P., Carter B. D., Dobrowsky R. T., and Chao M. V. (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716–719.
Frade J. M., Rodriguez-Tebar A., and Barde Y. A. (1996) Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383, 166–168.
Friedman W. J. (2000) Neurotrophins induce death of hippocampal neurons via the p75 receptor. J. Neurosci. 20, 6340–6346.
Roux P. P., Colicos M. A., Barker P. A., and Kennedy T. E. (1999) p75 neurotrophin receptor expression is induced in apoptotic neurons after seizure. J. Neurosci. 19, 6887–6896.
Troy C. M., Friedman J. E., and Friedman W. J. (2002) Mechanisms of p75-mediated death of hippocampal neurons: role of caspases. J. Biol. Chem. 277, 34,295–34,302.
Beattie M. S., Harrington A. W., Lee R., et al. (2002) ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36, 375–386.
Carter B. D. and Lewin G. R. (1997) Neurotrophins live or let die: does p75 decide? Neuron 18, 187–190.
Casaccia-Bonnefil P., Gu C., Khursigara G., and Chao M. V. (1999) p75 neurotrophin receptor as a modulator of survival and death decisions. Microsc. Res. Tech. 45, 217–224.
Lee R., Kermani P., Teng K. K., and Hempstead B. L. (2001) Regulation of cell survival by secreted proneurotrophins. Science 294, 1945–1948.
Chao M. V. and Bothwell M. (2002) Neurotrophins: to cleave or not to cleave. Neuron 33, 9–12.
Ibanez C. (2002) Jekyll-Hyde neurotrophins: the story of proNGF. Trends Neurosci. 25, 284–286.
Hempstead B. L. (2002) The many faces of p75NTR. Curr. Opin. Neurobiol. 12, 260–267.
Seidah N. G., Benjannet S., Pareek S., et al. (1996) Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem. J. 314 (Pt 3), 951–960.
Fahnestock M., Michalski B., Xu B., and Coughlin M. D. (2001) The precursor pronerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer’s disease. Mol. Cell Neurosci. 18, 210–220.
Pang P. T., Teng H. K., Zaitsev E., et al. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306, 487–491.
Harrington A., Leiner B., Blechschmitt C., et al. (2004) Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc. Natl. Acad. Sci. USA 101, 6226–6230.
Nykjaer A., Lee R., Teng K., et al. (2004) Sortilin is essential for proNGF-induced neuronal cell death. Nature 427, 843–848.
Hempstead B. L., Martin-Zanca D., Kaplan D. R., and Chao M. V. (1991) High affinity NGF binding requires co-expression of the trk proto-oncogene and the low affinity NGF receptor. Nature 350, 678–683.
Wang K. C., Kim J. A., Sivasankaran R., Segal R., and He Z. (2002) p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420, 74–78.
Wong S. T., Henley J. R., Kanning K. C., Huang K. H., Bothwell M., and Poo M. M. (2002) A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 11, 11.
Chao M. V. (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299–309.
Barker P. A. (2004) p75NTR is positively promiscuous: novel partners and new insights. Neuron 42, 529–533.
Salehi A. H., Roux P. P., Kubu C. J., et al. (2000) NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 27, 279–288.
Salehi A. H., Xanthoudakis S., and Barker P. A. (2002) NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway. J. Biol. Chem. 277, 48,043–48,050.
Linggi M. S., Burke T. L., Williams B. B., et al. (2005) NRIF is an essential mediator of apoptotic signaling by the p75 neurotrophin receptor. J. Biol. Chem. 8, 155–167.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Friedman, W.J. Interactions of interleukin-1 with neurotrophic factors in the central nervous system. Mol Neurobiol 32, 133–144 (2005). https://doi.org/10.1385/MN:32:2:133
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MN:32:2:133